首页> 美国卫生研究院文献>British Journal of Pharmacology and Chemotherapy >Inhibition of substance P-induced microvascular leakage by inhaled methoxamine in rat airways.
【2h】

Inhibition of substance P-induced microvascular leakage by inhaled methoxamine in rat airways.

机译:吸入甲氧明在大鼠气道中抑制P物质诱导的微血管渗漏。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

1. The effect of the inhaled alpha-adrenoceptor agonist, methoxamine (MTX), was studied on experimental airway oedema induced by injection of substance P (SP) in the rat. Sprague-Dawley rats (300-350 g) were anaesthetized with sodium thiopentone, tracheotomized and artificially ventilated. 2. MTX or its vehicle was administered by inhalation. Airway resistance and blood pressure were monitored continuously. Evans Blue dye (EB, 20 mg kg-1) was injected through a jugular catheter 1 min before SP (14.8 nmol kg-1). Airways were dissected out, weighed and placed in formamide for EB extraction and determination by spectrophotometry. 3. EB extravasation induced by SP was significantly reduced in distal intraparenchymal bronchi by inhaled MTX at doses of 50 micrograms kg-1 (58 +/- 9 vs 96 +/- 9 ng EB mg-1 tissue after vehicle, P < 0.001) and 100 micrograms kg-1 (69 +/- 11 vs 137 +/- 26 ng EB mg-1 tissue after vehicle, P < 0.01). Inhaled MTX by itself (100 micrograms kg-1) increased blood pressure: 172 +/- 6 vs 132 +/- 10 mmHg baseline (P < 0.02), but neither induced extravasation nor increased airway resistance. 4. In another set of experiments without SP, MTX was administered intravenously 1 min after EB. At 100 micrograms kg-1, i.v. MTX increased blood pressure to a similar extent as inhaled MTX (180 vs 147 mmHg baseline, P < 0.01), increased airway resistance and caused leakage of plasma proteins in distal intraparenchymal bronchi (79 +/- 7 vs 47 +/- 1 ng EB mg-1 tissue, P < 0.02).(ABSTRACT TRUNCATED AT 250 WORDS)
机译:1.研究了吸入的α-肾上腺素受体激动剂甲恶胺(MTX)对大鼠注射P物质(SP)引起的实验性气道水肿的作用。用硫代戊酮钠麻醉Sprague-Dawley大鼠(300-350 g),气管切开并人工通气。 2.通过吸入施用MTX或其媒介物。持续监测气道阻力和血压。在SP(14.8 nmol kg-1)之前1分钟,通过颈静脉导管注射伊文思蓝染料(EB,20 mg kg-1)。解剖出气道,称重并放入甲酰胺中,以进行EB提取和通过分光光度法测定。 3.在50μgkg-1的剂量下吸入MTX可以显着减少远端实质性内支气管中SP诱导的EB外渗(溶媒后58 +/- 9 vs 96 +/- 9 ng EB mg-1组织,P <0.001)和100微克kg-1(溶媒后69 +/- 11 vs 137 +/- 26 ng EB mg-1组织,P <0.01)。单独吸入MTX(100微克kg-1)可使血压升高:基线为172 +/- 6 vs基线为132 +/- 10 mmHg(P <0.02),但既不引起外渗,也不增加气道阻力。 4.在另一组无SP的实验中,在EB后1分钟静脉注射MTX。静脉注射100微克kg-1 MTX使血压升高的程度与吸入MTX相似(基线为180 vs 147 mmHg,P <0.01),气道阻力增加,并导致远端实质实质支气管血浆蛋白渗漏(79 +/- 7 vs 47 +/- 1 ng EB mg-1个组织,P <0.02)。(摘要截断为250个字)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号